- ICH GCP
- Registr klinických studií v USA
- Klinická studie NCT03524092
Udržovací studie Mirikizumabu u účastníků se středně těžkou až těžkou aktivní ulcerózní kolitidou (LUCENT 2)
Fáze 3, multicentrická, randomizovaná, dvojitě zaslepená, s paralelním ramenem, placebem kontrolovaná udržovací studie mirikizumabu u pacientů se středně těžkou až těžkou aktivní ulcerózní kolitidou (LUCENT 2)
Přehled studie
Postavení
Podmínky
Intervence / Léčba
Typ studie
Zápis (Aktuální)
Fáze
- Fáze 3
Kontakty a umístění
Studijní místa
-
-
-
Córdoba, Argentina, X5016KEH
- Hospital Privado Centro Medico de Cordoba SA
-
-
Buenos Aires
-
CABA, Buenos Aires, Argentina, C1027AAP
- Centro de Investigaciones Metabólicas (CINME)
-
Ciudad Autonoma de Buenos Air, Buenos Aires, Argentina, C1128AAF
- Mautalen Salud e Investigacion-Centro de Osteopatías Médicas
-
Quilmes, Buenos Aires, Argentina, B1878DVC
- Cer Instituto Medico
-
-
Santa Fe Province
-
Rosario, Santa Fe Province, Argentina, S2000DEJ
- Fundacion de Estudios Clinicos
-
-
Tucumán Province
-
SAN M. de Tucuman, Tucumán Province, Argentina, T4000AXL
- Centro de Investigaciones Medicas Tucuman
-
San Miguel de Tucumán, Tucumán Province, Argentina, 4000
- C.I.C.E. 9 de Julio
-
-
-
-
Essex
-
Harlow, Essex, Austrálie, CM20 1QX
- Princess Alexandra Hospital
-
-
Queensland
-
Maroochydore, Queensland, Austrálie, 4558
- Coastal Digestive Health
-
South Brisbane, Queensland, Austrálie, 4101
- Mater University Hospital
-
-
South Australia
-
Adelaide, South Australia, Austrálie, 5000
- Royal Adelaide Hospital
-
-
Victoria
-
Box Hill, Victoria, Austrálie, 3128
- Box Hill Hospital Outpatients
-
Malvern, Victoria, Austrálie, 3144
- Melbourne Gastrointestinal Investigation Unit (MGIU)
-
Melbourne, Victoria, Austrálie, 3004
- The Alfred Hospital
-
Parkville, Victoria, Austrálie, 3050
- The Royal Melbourne Hospital
-
-
-
-
-
Brasschaat, Belgie, 2930
- AZ Klina
-
Leuven, Belgie, 3000
- Universitaire Ziekenhuizen Leuven - Campus Gasthuisberg
-
-
Oost-Vlaanderen
-
Ghent, Oost-Vlaanderen, Belgie, 9000
- Universitair Ziekenhuis Gent
-
-
Wallonne, Région
-
Tournai, Wallonne, Région, Belgie, 7500
- Centre Hospitalier de Wallonie Picarde - Site Notre Dame
-
-
-
-
-
Herlev, Dánsko, 2730
- Herlev and Gentofte Hospital
-
Køge, Dánsko, 4600
- Zealand University Hospital Køge
-
-
-
-
-
Chambray-lès-Tours, Francie, 37170
- CHU Tours - Hôpital Trousseau
-
Marseille, Francie, 13915
- Assistance Publique Hôpitaux de Marseille - Hôpital Nord
-
Montpellier, Francie, 34295
- CHRU de Montpellier-Hopital St Eloi
-
Nice, Francie, 06200
- Hopital L'Archet 2
-
Pessac, Francie, 33604
- CHU Bordeaux - Hôpital Haut-Lévêque
-
Reims, Francie, 51092
- Robert Debré Hospital
-
Saint-Priest-en-Jarez, Francie, 42270
- CHU de Saint Etienne Hopital Nord
-
Vandœuvre-lès-Nancy, Francie, 54500
- CHRU Nancy Brabois - Hôpital d'Enfants
-
-
Bas Rhin
-
Strasbourg, Bas Rhin, Francie, 67098
- Hopital de Hautepierre - Service d'Hépatogastroentérolgie
-
-
Cedex 10
-
Paris, Cedex 10, Francie, 75475
- Hôpital Saint-Louis
-
-
Nord
-
Lille, Nord, Francie, 59037
- CHU Lille - Hôpital Claude Huriez
-
-
Paris
-
Clichy, Paris, Francie, 92110
- Hôpital Beaujon
-
-
Pyrénées-Atlantiques
-
Pau, Pyrénées-Atlantiques, Francie, 64046
- Centre Hospitalier de Pau
-
-
Rhone
-
Pierre-Bénite, Rhone, Francie, 69495
- Hospices Civils de Lyon - Centre Hospitalier Lyon Sud -
-
-
Somme
-
Amiens, Somme, Francie, 80480
- CHU Amiens Picardie-Site Sud - RDC Service Hépato gastro
-
-
-
-
-
Uden, Holandsko, 5406 PT
- Bernhoven Ziekenhuis
-
Utrecht, Holandsko, 3584 CX
- UMC Utrecht, Dept. of Internal Medicine, MDL
-
-
North Brabant
-
Tilburg, North Brabant, Holandsko, 5022 GC
- St Elisabeth Ziekenhuis
-
-
North Holland
-
Amsterdam, North Holland, Holandsko, 1105 AZ
- Amsterdam UMC, locatie AMC
-
-
-
-
Andhra Pradesh
-
Hyderabad, Andhra Pradesh, Indie, 500058
- Centre for Liver Research & Diagnostics, Deccan College of Medical Sciences, Owaisi Hospital & Research Centre
-
-
Gujarat
-
Gandhinagar, Gujarat, Indie, 382428
- Apollo Research and Innovations, Apollo Hospitals International Ltd
-
Rajkot, Gujarat, Indie, 360005
- Shree Giriraj Multispeciality Hospital
-
Surat, Gujarat, Indie, 395002
- Nirmal Hospital Pvt Ltd.
-
-
Karnataka
-
Bangalore, Karnataka, Indie, 560054
- M S Ramaiah Medical College and Hospitals
-
Bangalore, Karnataka, Indie, 560 002
- Bangalore Medical College and Research Institute
-
-
Maharashtra
-
Nagpur, Maharashtra, Indie, 440010
- Midas Multispeciality Hospital Pvt.Ltd.
-
Pune, Maharashtra, Indie, 411 001
- Poona Medical Foundation. Ruby Hall Clinic
-
Wardha, Maharashtra, Indie, 442004
- Datta Meghe Institute of Medical Sciences (DU), Acharya Vinoba Bhave Rural Hospital
-
-
National Capital Territory of Delhi
-
New Delhi, National Capital Territory of Delhi, Indie, 110 025
- Escorts Heart Institute and Research Centre Ltd
-
-
Punjab
-
Ludhiana, Punjab, Indie, 141001
- Dayanand Medical College and Hospital
-
-
Rajasthan
-
Jaipur, Rajasthan, Indie, 302001
- SR Kalla Memorial Gastro & General Hospital
-
-
Telangana
-
Hyderabad, Telangana, Indie, 500003
- Gandhi Hospital
-
-
Uttar Pradesh
-
Lucknow, Uttar Pradesh, Indie, 226003
- King George Medical University
-
-
-
-
-
Dublin, Irsko, D9
- Beaumont Hospital, Dublin
-
-
-
-
-
Brescia, Itálie, 25123
- Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (Presidio Spedali Civili)
-
Catanzaro, Itálie, 88100
- Azienda ospedaliero-universitaria Mater Domini
-
Genova, Itálie, 16132
- Azienda Ospedaliero Universitaria San Martino
-
Milan, Itálie, 20122
- Gastroenterology and Endoscopy Unit IRCCS Ca' Granda Ospedale Maggiore Policlinico Foundation
-
Modena, Itálie, 41124
- Azienda Ospedaliera Universitaria Policlinico de Modena
-
Pisa, Itálie, 56124
- Azienda Ospedaliera Universitaria Pisana
-
Roma, Itálie, 00168
- Policlinico Gemelli - Università Cattolica del Sacro Cuore
-
Torino, Itálie, 10128
- Ospedale Mauriziano Umberto I
-
Udine, Itálie, 33100
- Azienda Ospedaliero-Universitaria Santa Maria della Misericordia Gastroenterologia
-
-
Milano
-
Rho, Milano, Itálie, 20017
- Presidio di Rho
-
Rozzano, Milano, Itálie, 20089
- Istituto Clinico Humanitas
-
San Donato Milanese, Milano, Itálie, 20097
- Istituti di Ricovero e Cura a Carattere Scientifico Policlinico San Donato Gastroenterologia
-
-
Roma
-
Rome, Roma, Itálie, 00157
- Ospedale Sandro Pertini
-
Torre, Roma, Itálie, 00133
- Azienda Ospedaliera Universitaria Policlinico Tor Vergata
-
-
-
-
-
Beersheba, Izrael, 8410101
- Soroka Medical Center - Pediatric Outpatient Clinic
-
Nahariya, Izrael, 2210001
- Galilee Medical Center Department of Internal Medicine A
-
Rehovot, Izrael, 7610001
- Kaplan Medical Center
-
Tel Aviv, Izrael, 6423906
- Tel Aviv Sourasky Medical Center
-
Ẕerifin, Izrael, 70300
- King Fahad Medical City
-
-
Jerusalem
-
Bait Vagan, Jerusalem, Izrael, 91031
- Shaare Zedek Medical Center
-
-
-
-
-
Fukuoka, Japonsko, 814-0180
- Fukuoka University Hospital
-
Hiroshima, Japonsko, 734-8551
- Hiroshima University Hospital
-
Kagoshima, Japonsko, 892-0846
- Sameshima Hospital
-
Kyoto, Japonsko, 612-8555
- National Hospital Organization Kyoto Medical Center
-
Okayama, Japonsko, 700-8558
- Okayama University Hospital
-
Saitama, Japonsko, 336-0963
- Tokitokai Tokito Clinic
-
Toyama, Japonsko, 930-0975
- Toyama Prefectural Central Hospital
-
-
Aichi-ken
-
Nagakute-shi, Aichi-ken, Japonsko, 480-1195
- Aichi Medical University Hospital
-
Toyoake, Aichi-ken, Japonsko, 470-1192
- Fujita Health University
-
-
Aomori
-
Hirosaki, Aomori, Japonsko, 036-8545
- National Hospital Organization Hirosaki National Hospital
-
-
Chiba
-
Sakura, Chiba, Japonsko, 285-8741
- Toho University Sakura Medical Center
-
-
Fukoka
-
Kitakyusyu-shi, Fukoka, Japonsko, 802-0077
- Kitakyushu Municipal Medical Center
-
-
Fukuoka
-
Chikushino-shi, Fukuoka, Japonsko, 818-8502
- Fukuoka University Chikushi Hospital
-
Kurume-shi, Fukuoka, Japonsko, 839 0809
- Hidaka Coloproctology Clinic
-
-
Gunma
-
Maebashi, Gunma, Japonsko, 371-8511
- Gunma University Hospital
-
Takasaki, Gunma, Japonsko, 370-0829
- National Hospital Organization Takasaki General Medical Centar
-
-
HigaShiibaraki-Gun
-
Ibaraki-machi, HigaShiibaraki-Gun, Japonsko, 311 3193
- NHO Mito Medical Center
-
-
Hokkaido
-
Asahikawa, Hokkaido, Japonsko, 070-8610
- Asahikawa City Hospital
-
Sapporo, Hokkaido, Japonsko, 065-0033
- Sapporo Higashi Tokushukai Hospital
-
Sapporo, Hokkaido, Japonsko, 004 0041
- Tokushukai Sapporo Tokushukai Hospital
-
Sapporo, Hokkaido, Japonsko, 060 0033
- Hokkaido P.W.F.A.C. Sapporo-Kosei General Hospital
-
-
Hyōgo
-
Kobe, Hyōgo, Japonsko, 650 0015
- Aoyama Clinic GI Endoscopy & IBD Center
-
-
Kagawa-ken
-
Takamatsu, Kagawa-ken, Japonsko, 760-8557
- Kagawa Prefectural Central Hospital
-
-
Kanagawa
-
Kamakura, Kanagawa, Japonsko, 247-0056
- Ofuna Central Hospital
-
Kawasaki, Kanagawa, Japonsko, 210-0013
- Kawasaki Municipal Hospital
-
Yokohama, Kanagawa, Japonsko, 232-0024
- Yokohama City University Medical Center
-
Yokohama, Kanagawa, Japonsko, 234-0032
- Showa University Northern Yokohama Hospital
-
Yokohama, Kanagawa, Japonsko, 226 0025
- Sankikai Yokohama Shin midori General Hospital
-
-
Kumamoto
-
Kumamoto, Kumamoto, Japonsko, 860-0012
- Kumamoto University Hospital
-
-
Mie-ken
-
Tsu, Mie-ken, Japonsko, 514-8507
- Mie University Hospital
-
-
Miyagi
-
Sendai, Miyagi, Japonsko, 981 3213
- Takagi Clinic - Sendai
-
-
Niigata
-
Nagaoka-shi, Niigata, Japonsko, 940-8653
- Nagaoka Chuo General Hospital
-
-
Oita Prefecture
-
Ōita, Oita Prefecture, Japonsko, 870 0823
- Ishida Clinic of IBD and Gastroenterology
-
-
Osaka
-
Fujiidera, Osaka, Japonsko, 583-0027
- Sai Gastroenterologist Proctology
-
Osaka, Osaka, Japonsko, 530 0011
- Infusion Clinic
-
Osaka, Osaka, Japonsko, 540 0006
- NHO Osaka National Hospital
-
-
Saga-ken
-
Saga, Saga-ken, Japonsko, 840-8571
- Saga-Ken Medical Center Koseikan
-
-
Saitama
-
Kumagaya-shi, Saitama, Japonsko, 360-8567
- Kumagaya General Hospital
-
-
Shizuoka
-
Hamamatsu, Shizuoka, Japonsko, 4328061
- Matsuda Hospital
-
-
Tochigi
-
Shimotsuke-shi, Tochigi, Japonsko, 329-0498
- Jichi Medical University Hospital
-
-
Tokyo
-
Bunkyo-ku, Tokyo, Japonsko, 113-8431
- Juntendo University Hospital
-
Bunkyō, Tokyo, Japonsko, 113-8519
- Tokyo Medical and Dental University Hospital
-
Koto-ku, Tokyo, Japonsko, 135 8577
- Showa University Koto Toyosu Hospital
-
Minato-Ku, Tokyo, Japonsko, 108 8642
- Kitasato University Kitasato Institute Hospital
-
Mitaka, Tokyo, Japonsko, 181-8611
- Kyorin University Hospital
-
Shinjuku-ku, Tokyo, Japonsko, 169-0073
- JHCO Tokyo Yamate Medical Center
-
-
Tokyo-To
-
Chiyoda-ku, Tokyo-To, Japonsko, 101-8643
- Mitsui Memorial Hospital
-
Shinjuku-ku, Tokyo-To, Japonsko, 162 8655
- Center Hospital of the National Center for Global Health and Medicine
-
-
-
-
-
Busan, Jižní Korea, 48108
- Inje University Haeundae Paik Hospital
-
Daegu, Jižní Korea, 42415
- Yeungnam Univeristy Medical Center
-
-
Gangwon-do
-
Wŏnju, Gangwon-do, Jižní Korea, 26426
- Severance Hospital, Yonsei University Health System
-
-
Korea
-
Seoul, Korea, Jižní Korea, 02447
- Kyung Hee University Hospital
-
-
Pusan-Kwangyǒkshi
-
Busan, Pusan-Kwangyǒkshi, Jižní Korea, 49201
- Dong-A University Hospital
-
-
Seoul-teukbyeolsi [Seoul]
-
Seoul, Seoul-teukbyeolsi [Seoul], Jižní Korea, 06351
- Samsung Medical Center
-
Seoul, Seoul-teukbyeolsi [Seoul], Jižní Korea, 05505
- Asan Medical Center
-
Seoul, Seoul-teukbyeolsi [Seoul], Jižní Korea, 03181
- Kangbuk Samsung Hospital
-
-
Taejǒn-Kwangyǒkshi
-
Daejeon, Taejǒn-Kwangyǒkshi, Jižní Korea, 34943
- The Catholic University of Korea, Daejeon St. Mary's Hospital
-
-
-
-
Alberta
-
Edmonton, Alberta, Kanada, T5R 1W2
- West Edmonton Diabetes Center
-
-
British Columbia
-
Vancouver, British Columbia, Kanada, V6Z 2K5
- GI Research Institute
-
Vancouver, British Columbia, Kanada, V5Z 1M9
- The Gordon and Leslie Diamond Health Care Centre
-
Victoria, British Columbia, Kanada, V8V 3M9
- PerCuro Clinical Research
-
-
Ontario
-
London, Ontario, Kanada, N6A 4G5
- Victoria Hospital
-
London, Ontario, Kanada, N6A 5G1
- University of Western Ontario
-
-
Quebec
-
Greenfield Park, Quebec, Kanada, J4V 2H1
- Centre de santé et de services sociaux Champlain-Charles-Le Moyne
-
Montreal, Quebec, Kanada, H1T 2M4
- Hopital Maisonneure-Rosemount
-
Montreal, Quebec, Kanada, H3G 1A4
- Inflammatory Bowel Disease Centre Montreal General Hospital - MUHC
-
-
-
-
-
Kaunas, Litva, 50009
- Hospital of Lithuanian University of Health Sciences Kaunas
-
Klaipėda, Litva, 92288
- Klaipeda Seamen's Hospital
-
Klaipėda, Litva, 92231
- Republic Hospital of Klaipeda
-
Vilnius, Litva, LT-08661
- Vilnius University Hospital Santariskiu Clinics
-
-
Panevėžys
-
Panevezys, Panevėžys, Litva, LT-35144
- Respublikine Panevezio ligonine
-
-
-
-
-
Riga, Lotyšsko, 1079
- Digestive Diseases Center "Gastro"
-
Riga, Lotyšsko, LV-1038
- Riga Eastern Clinical University Hospital
-
-
Riga
-
Riga, Riga, Lotyšsko, LV-1002
- Pauls Stradins Clinical Univeristy Hospital
-
-
-
-
Kelantan
-
Kubang Kerian, Kelantan, Malajsie, 16150
- Universiti Sains Malaysia
-
-
Kuala Lumpur
-
Lembah Pantai, Kuala Lumpur, Malajsie, 59100
- University Malaya Medical Centre
-
-
Selangor
-
Ampang, Selangor, Malajsie, 68000
- Hospital Ampang
-
-
-
-
-
Budapest, Maďarsko, 1088
- Semmelweis Egyetem
-
Budapest, Maďarsko, 1036
- Óbudai Egészségügyi Centrum
-
Debrecen, Maďarsko, 4032
- Debreceni Egyetem Klinikai Kozpont
-
Miskolc, Maďarsko, 3526
- Endomedix Diagnosztikai Központ - Miskolc
-
Mosonmagyaróvár, Maďarsko, 9200
- Karolina Korhaz-Rendelointezet
-
Szeged, Maďarsko, 6720
- Szegedi Tudomanyegyetem Szent-Gyorgyi Albert Klinikai Kozpont I. Belgyogyaszati Klinika
-
Szekszárd, Maďarsko, 7100
- CLINFAN Szolgáltató Kft
-
-
EU
-
Balatonfüred, EU, Maďarsko, 8230
- DRC Gyogyszervizsgalo Kozpont Kft.
-
-
Pest County
-
Vác, Pest County, Maďarsko, 2600
- Javorszky Odon Korhaz
-
-
-
-
-
Chihuahua City, Mexiko, 31203
- Scientia Investigacion Clinica S.C.
-
Veracruz, Mexiko, 91900
- Sociedad de Metabolismo y Corazon
-
-
Jalisco
-
Zapopan, Jalisco, Mexiko, 45030
- Investigacion Biomedica para el Desarrollo de Farmacos S.A. de C.V.
-
-
Mexico City
-
Mexico City, Mexico City, Mexiko, 07020
- Centro de Investigación Clínica Acelerada
-
-
Sinaloa
-
Culiacán, Sinaloa, Mexiko, 80230
- Centro Para el Desarrollo de la Medicina y de Asistencia Medica S.C
-
-
-
-
-
Berlin, Německo, 14163
- Krankenhaus Waldfriede
-
Berlin, Německo, 12203
- Charité Campus Virchow-Klinikum
-
Brandenburg, Německo, 14770
- Städtisches Klinikum Brandenburg
-
Hamburg, Německo, 20251
- HaFCED - Hamburgisches Forschungsinstitut für chronisch entzündliche Darmerkrankungen
-
Weyhe, Německo, 28844
- Internistische Praxisgemeinschaft
-
-
Lower Saxony
-
Hanover, Lower Saxony, Německo, 30625
- Medizinische Hochschule Hanover
-
-
Rhineland-Palatinate
-
Ludwigshafen am Rhein, Rhineland-Palatinate, Německo, 67067
- Gemeinschaftspraxis Dr. Peter Uebel
-
-
Saxony-Anhalt
-
Halle, Saxony-Anhalt, Německo, 06108
- Studiengesellschaft BSF Unternehmergesellschaft
-
Halle, Saxony-Anhalt, Německo, 06120
- Universitatsklinikum Halle
-
-
-
-
-
Katowice, Polsko, 40-660
- All-Medicus
-
Olsztyn, Polsko, 10-561
- Wojewodzki Specjalistyczny Szpital w Olsztynie
-
Szczecin, Polsko, 71-434
- Twoja Przychodnia - Szczecinskie Centrum Medyczne
-
Torun, Polsko, 87-100
- Gastromed Kopoń Zmudziński I Wspólnicy Spółka Jawna Specjalistyczne Centrum Gastrologii I Endoskopii
-
Warsaw, Polsko, 00-728
- Warsaw IBD Point Profesor Kierkus
-
Warsaw, Polsko, 00635
- Centrum Zdrowia MDM
-
Warsaw, Polsko, 01-697
- Centrum Medyczne Neuroprotect
-
Wroclaw, Polsko, 52-210
- PlanetMed Sp.z o.o.
-
Zamość, Polsko, 22-400
- ETG Zamosc
-
-
Kuyavian-Pomeranian Voivodeship
-
Bydgoszcz, Kuyavian-Pomeranian Voivodeship, Polsko, 85-168
- Szpital Uniwersytecki Nr 2 im. dr J. Biziela w Bydgoszczy
-
-
Lesser Poland Voivodeship
-
Krakow, Lesser Poland Voivodeship, Polsko, 31-506
- Topolowa Medicenter
-
Nowy Targ, Lesser Poland Voivodeship, Polsko, 34-400
- Medicenter Nowy Targ
-
Wadowice, Lesser Poland Voivodeship, Polsko, 34-100
- NZOZ Formed
-
-
Lower Silesian Voivodeship
-
Wroclaw, Lower Silesian Voivodeship, Polsko, 53-114
- LexMedica
-
-
Lublin Voivodeship
-
Lublin, Lublin Voivodeship, Polsko, 20-954
- Samodzielny Publiczny Szpital Kliniczny Nr 4 w Lublinie
-
Lublin, Lublin Voivodeship, Polsko, 20-582
- ZOZ Gastromed
-
-
Masovian Voivodeship
-
Warsaw, Masovian Voivodeship, Polsko, 03-580
- NZOZ Vivamed
-
-
Silesian Voivodeship
-
Będzin, Silesian Voivodeship, Polsko, 42-500
- Promedica Dental Clinic
-
-
West Pomeranian Voivodeship
-
Szczecin, West Pomeranian Voivodeship, Polsko, 71-685
- SONOMED Centrum Medyczne
-
-
Świętokrzyskie Voivodeship
-
Straszów, Świętokrzyskie Voivodeship, Polsko, 28-200
- KO-Med Centrum Medyczne
-
-
-
-
-
Innsbruck, Rakousko, 6020
- Medizinische Universitat Innsbruck
-
Salzburg, Rakousko, 5020
- Universitätsklinikum Salzburg
-
Vienna, Rakousko, 1090
- Medical University of Vienna
-
-
-
-
-
Bucharest, Rumunsko, 022328
- Institutul Clinic Fundeni
-
Bucharest, Rumunsko, 020125
- Spitalul Clinic Colentina
-
Bucharest, Rumunsko, 010719
- MedLife Grivita
-
Bucharest, Rumunsko, 031864
- Hifu Terramed Conformal SRL
-
Oradea, Rumunsko, 410469
- Spital Pelican Oradea
-
-
Bucharest
-
Bucharest, Bucharest, Rumunsko, 030463
- CCBR Clinical Research
-
-
-
-
-
Barnaul, Rusko, 656043
- Multidisciplinary Medical Clinic "Anthurium"
-
Cherepovets, Rusko, 162600
- Medical and Sanitary Division of Severstal
-
Izhevsk, Rusko, 426061
- Alliance Biomedical URAL Group
-
Kaliningrad, Rusko, 236035
- Clinical Trials Center of Medical Institute
-
Kazan', Rusko, 420064
- State Autonomous Institution of Healthcare "Republican Clinical Hospital of the Ministry of Healthcare of Republic Tatarstan
-
Kemerovo, Rusko, 650066
- SIH Kemerovo Regional Clinical Hosptial
-
Moscow, Rusko, 125367
- Medical rehabilitation center
-
Novosibirsk, Rusko, 630005
- LLC "Medicine Center SibNovoMed"
-
Omsk, Rusko, 644024
- Clinical Diagnostic Center Ultramed
-
Saint Petersburg, Rusko, 191104
- City Mariinskaya Hospital
-
Saint Petersburg, Rusko, 195067
- Pokrovskaya Municipal Hospital
-
Saint Petersburg, Rusko, 195271
- Non-state Healthcare Institution "Roadway Clinical Hospital of OJSC Russian Railways
-
Saint Petersburg, Rusko, 197022
- Saint Petersburg State Medical University n.a. Pavlov I.P.
-
Saint Petersburg, Rusko, 197110
- SBIH City Clinical Hospital #31
-
Samara, Rusko, 443001
- Medical Institute REAVIZ
-
Stavropol, Rusko, 355018
- Stavropol State Medical University
-
Yaroslavl, Rusko, 150030
- Yaroslavl Municipal HI Clinical Hospital #8
-
Yekaterinburg, Rusko, 620109
- LLC MA New Hospital
-
-
Irkutsk Oblast
-
Irkutsk, Irkutsk Oblast, Rusko, 664079
- Scientific Centre of Reconstructive and Restorative Surgery
-
-
Kareliya, Respublika
-
Petrozavodsk, Kareliya, Respublika, Rusko, 185019
- Karelia Republican Hospital V.A. Baranova
-
-
Nizhny Novgorod Oblast
-
Nizhny Novgorod, Nizhny Novgorod Oblast, Rusko, 603126
- Nizhny Novgorod Regional Hospital N.A. Semashko
-
Nizhny Novgorod, Nizhny Novgorod Oblast, Rusko, 603140
- Private Healthcare Institution Clinical Hospital Russian Railways - Medicine of Nizhniy Novgorod
-
-
Novosibirsk Oblast
-
Novosibirsk, Novosibirsk Oblast, Rusko, 630007
- Novosibirski Gastrocenter
-
-
Rostov Oblast
-
Rostov-on-Don, Rostov Oblast, Rusko, 344091
- Rostov State Medical University
-
-
Sankt-Peterburg
-
Saint Petersburg, Sankt-Peterburg, Rusko, 196143
- Scientific research center ECO-security
-
-
-
-
-
Banská Bystrica, Slovensko, 975 17
- Fakultna nemocnica s poliklinikou Roosevelta Banska Bystrica
-
Bratislava, Slovensko, 82007
- Univerzitna nemocnica Bratislava
-
-
Nitra Region
-
Nitra, Nitra Region, Slovensko, 949 01
- KM Management
-
-
Presov
-
Prešov, Presov, Slovensko, 080 01
- Gastro
-
Vranov N. Toplou, Presov, Slovensko, 093 01
- Endomed, s.r.o.
-
-
-
-
Essex
-
Romford, Essex, Spojené království, RM7 0AG
- Queens Hospital
-
-
Great Britain
-
Bury, Great Britain, Spojené království, BL9 7TD
- Fairfield General Hospital
-
-
London
-
Great Maze Pond, London, Spojené království, SE1 9RT
- St Thomas' Hospital
-
-
Surrey
-
London, Surrey, Spojené království, E11 1NR
- Whipps Cross University Hospital
-
-
Swansea [Abertawe Gb-ata]
-
Swansea, Swansea [Abertawe Gb-ata], Spojené království, SA6 6SG
- Morriston Hospital
-
-
Vinnytsia
-
Leeds, Vinnytsia, Spojené království, LS9 7TF
- St James's University Hospital
-
-
-
-
Alabama
-
Dothan, Alabama, Spojené státy, 36305
- Digestive Health Specialists of the Southeast
-
-
Arizona
-
Litchfield Park, Arizona, Spojené státy, 85340
- Dcr-Pi, Pc
-
Phoenix, Arizona, Spojené státy, 85008
- Maricopa Integrated Health System
-
Tempe, Arizona, Spojené státy, 85284
- Physicians Research Group
-
-
California
-
Arcadia, California, Spojené státy, 91006
- Valley Gastroenterology
-
Berkeley, California, Spojené státy, 94705
- Care Access Research
-
Lancaster, California, Spojené státy, 93534
- Om Research, LLC
-
Northridge, California, Spojené státy, 91324
- California Medical Research Associates
-
San Diego, California, Spojené státy, 92103
- Clinical Applications Laboratories, Inc.
-
San Francisco, California, Spojené státy, 94158
- UCSF Medical Center at Mission Bay
-
-
Florida
-
Hialeah, Florida, Spojené státy, 33012
- Direct Helpers Research Center
-
Inverness, Florida, Spojené státy, 34452
- Nature Coast Clinical Research, LLC
-
Kissimmee, Florida, Spojené státy, 34741
- SIH Research, LLC
-
Miami, Florida, Spojené státy, 33134
- Research Associates of South Florida, LLC
-
Miami Lakes, Florida, Spojené státy, 33016
- Wellness Clinical Research
-
Orlando, Florida, Spojené státy, 32818
- Clintheory Healthcare
-
Orlando, Florida, Spojené státy, 32803
- Center for Interventional Endoscopy
-
Pensacola, Florida, Spojené státy, 32503
- Gastroenterology Associates of Pensacola, PA
-
Zephyrhills, Florida, Spojené státy, 33542-7505
- Florida Medical Clinic LLC
-
-
Georgia
-
Atlanta, Georgia, Spojené státy, 30309
- Digestive Healthcare of Georgia
-
-
Idaho
-
Idaho Falls, Idaho, Spojené státy, 83404
- Grand Teton Research Group
-
-
Illinois
-
Evanston, Illinois, Spojené státy, 60201
- NorthShore University Healthsystem
-
-
Indiana
-
Indianapolis, Indiana, Spojené státy, 46202
- Indiana University School of Medicine
-
-
Kansas
-
Topeka, Kansas, Spojené státy, 66606
- Cotton-O'Neil Clinical Research Center, Digestive Health
-
-
Louisiana
-
Baton Rouge, Louisiana, Spojené státy, 70809
- Texas Digestive Disease Consultants
-
Monroe, Louisiana, Spojené státy, 71201
- Delta Research Partners LLC
-
New Orleans, Louisiana, Spojené státy, 70125
- Nola Research Works, LLC
-
-
Michigan
-
Chesterfield, Michigan, Spojené státy, 48047
- Clinical Research Institute of Michigan, LLC
-
Novi, Michigan, Spojené státy, 48377
- Henry Ford Health System
-
Wyoming, Michigan, Spojené státy, 49519
- Gastroenterology Associates of Western Michigan, P.L.C.
-
Ypsilanti, Michigan, Spojené státy, 48197
- Huron Gastroenterology Associates
-
-
Minnesota
-
Plymouth, Minnesota, Spojené státy, 55446
- MNGI Digestive Health - Plymouth Endoscopy Center & Clinic
-
-
Mississippi
-
Jackson, Mississippi, Spojené státy, 39206
- Care Access Research LLC
-
Tupelo, Mississippi, Spojené státy, 38801
- Digestive Health Specialists
-
-
New York
-
Great Neck, New York, Spojené státy, 11021
- Northwell Health
-
New York, New York, Spojené státy, 10021
- Weill Cornell Medical College
-
-
North Carolina
-
Chapel Hill, North Carolina, Spojené státy, 27599
- University of North Carolina Center for Inflammatory Bowel Disease
-
Greenville, North Carolina, Spojené státy, 27834
- Carolina Digestive Diseases and Endoscopy Center
-
-
Ohio
-
Middleburg Heights, Ohio, Spojené státy, 44130
- Paramount Medical Research
-
Poland, Ohio, Spojené státy, 44514
- Care Access - Youngstown
-
-
Oklahoma
-
Norman, Oklahoma, Spojené státy, 73071
- Central Sooner Research
-
Oklahoma City, Oklahoma, Spojené státy, 73104
- University of Oklahoma Health Sciences Center
-
-
Pennsylvania
-
Wyomissing, Pennsylvania, Spojené státy, 19610
- Digestive Disease Associates
-
-
South Dakota
-
Sioux Falls, South Dakota, Spojené státy, 57108
- Midwest Medical Care
-
-
Tennessee
-
Germantown, Tennessee, Spojené státy, 38138
- Gastro One
-
Hixson, Tennessee, Spojené státy, 37343
- Galen Medical Group
-
-
Texas
-
Garland, Texas, Spojené státy, 75044
- Digestive Health Associates of Texas
-
Houston, Texas, Spojené státy, 77043
- Biopharma Informatic, LLC
-
Houston, Texas, Spojené státy, 77030
- Houston Methodist Research Ins
-
San Antonio, Texas, Spojené státy, 78229
- Southern Star Research Institute, LLC
-
San Antonio, Texas, Spojené státy, 78229
- Gastroenterology Research of San Antonio
-
Southlake, Texas, Spojené státy, 76092
- Texas Digestive Disease Consultants
-
-
Utah
-
Ogden, Utah, Spojené státy, 84403
- Care Access Research LLC - Salt Lake City
-
-
Virginia
-
Leesburg, Virginia, Spojené státy, 20176
- Emeritas Research Group
-
Reston, Virginia, Spojené státy, 20191
- The Gastroenterology Group, P.C.
-
Roanoke, Virginia, Spojené státy, 24016
- Carilion Clinic
-
-
Wisconsin
-
Milwaukee, Wisconsin, Spojené státy, 53215
- Wisconsin Center for Advanced Research
-
-
-
-
-
Kragujevac, Srbsko, 34000
- Clinical Center Kragujevac Gastroenterohepatology Clinic
-
-
Beograd
-
Belgrade, Beograd, Srbsko, 11000
- Clinical Hospital Center Zvezdara
-
-
NAP
-
Belgrade, NAP, Srbsko, 11080
- University Medical Center "Bezanijska kosa"
-
-
Vojvodina
-
Sombor, Vojvodina, Srbsko, 25000
- Regional Hospital Dr Radivoj Simonovic Sombor
-
Sremska Mitrovica, Vojvodina, Srbsko, 22000
- Sremska Mitrovica Health Centre
-
Zrenjanin, Vojvodina, Srbsko, 23000
- General Hospital "Djordje Joanovic"
-
-
-
-
-
Taichung, Tchaj-wan, 40447
- China Medical University Hospital
-
Taipei, Tchaj-wan, 10002
- Health management center
-
-
-
-
Antalya
-
Kocaeli, Antalya, Turecko (Türkiye), 7100
- Antalya Egitim ve Arastırma Hastanesi
-
-
Istanbul
-
Kadıköy, Istanbul, Turecko (Türkiye), 34734
- Acibadem Universitesi - Acibadem Kozyatagi Hastanesi
-
-
Kocaeli
-
İzmit, Kocaeli, Turecko (Türkiye), 41380
- Kocaeli University Medical Faculty Hospital
-
-
Mersin
-
Yenişehir, Mersin, Turecko (Türkiye), 33110
- Mersin University Medical Faculty
-
-
Turkey
-
Izmir, Turkey, Turecko (Türkiye), 35100
- Ege Universitesi Hastanesi
-
-
-
-
-
Kharkiv, Ukrajina, 61039
- GI L.T. Malaya TI Namsu
-
Kharkiv, Ukrajina, 61002
- Kharkiv City Student Hospital
-
Kropyvnytskyi, Ukrajina, 25006
- Treatment-Diagnostic Center of Private Enterprise of PPC Atsynus
-
Kyiv, Ukrajina, 02091
- Kyiv Municipal Clinical Hospital #1
-
Kyiv, Ukrajina, 04107
- Communal institution of the Kyiv Regional Council "Kyiv Regional Clinical Oncology Dispensary"
-
Kyiv, Ukrajina, 04078
- Communal institution of the Kyiv Regional Council "Kyiv Regional Clinical Oncology Dispensary"
-
Odesa, Ukrajina, 65000
- Communal Enterprise "Odesa Regional Clinical Hospital"
-
Uzhhorod, Ukrajina, 88000
- A. Novak Transcarpathian Regional Clinical Hospital
-
Vinnytsia, Ukrajina, 21029
- CCH #1 Vinnytsia M.I. Pyrogov NMU Ch of Propaedeutics of IM
-
Vinnytsia, Ukrajina, 21005
- Vinnytsia RCH of Veterans of War Dept of Therapy#1 Vinnytsia M.I.Pyrogov NMU
-
Vinnytsia, Ukrajina, 21009
- MCIC MC LLC Health Clinic
-
Vinnytsia, Ukrajina, 21018
- M.I. Pyrogov Regional Clinical Hospital
-
Zaporizhzhia, Ukrajina, 69104
- Communal Institution of Kyiv Regional Council Kyiv Regional Hospital #2
-
-
Ivano-Frankivsk Oblast
-
Ivano-Frankivsk, Ivano-Frankivsk Oblast, Ukrajina, 76008
- Ivano-Frankivsk Regional Clinical Hospital
-
-
Kharkivs’ka Oblast’
-
Kharkiv, Kharkivs’ka Oblast’, Ukrajina, 61037
- City Clinical Hospital No. 2
-
-
Kherson Oblast
-
Kherson, Kherson Oblast, Ukrajina, 73000
- Kherson City Clinical Hospital
-
-
Kyiv Oblast
-
Kiev, Kyiv Oblast, Ukrajina, 4050
- Medical Center of Limited Liability Company "Medical Center "Consilium Medical"
-
-
Lviv Oblast
-
Lviv, Lviv Oblast, Ukrajina, 79000
- Lviv Railway Clinical Hospital
-
Lviv, Lviv Oblast, Ukrajina, 79000
- Lviv Regional Endocrinology Dispensary
-
Lviv, Lviv Oblast, Ukrajina, 79000
- Municipal non-profit enterprise "Lviv Territorial Medical Union "Multidisciplinary Clinical Hospital of Em -T
-
-
Poltava Oblast
-
Poltava, Poltava Oblast, Ukrajina, 36000
- Poltova Oblast Clinical Hospital IM.M.V.Sklifosovskoho
-
-
Zaporizhzhia Oblast
-
Zaporizhia, Zaporizhzhia Oblast, Ukrajina, 69076
- Diaservis - Medical and Diagnostic Center
-
-
-
-
-
Brno, Česko, 65691
- Fakultni nemocnice u sv. Anny v Brne
-
Olomouc, Česko, 779
- PreventaMed, s.r.o.
-
Prague, Česko, 19000
- ISCARE Clinical Centre
-
-
Brno-město
-
Brno, Brno-město, Česko, 636 00
- Vojenska nemocnice Brno
-
-
Hl. M. Praha
-
Prague, Hl. M. Praha, Česko, 100 34
- Fakultni nemocnice Kralovske Vinohrady
-
-
Hradec Králové
-
Hradec Králové, Hradec Králové, Česko, 500 12
- Hepato-Gastroenterologie HK
-
-
Olomouc Region
-
Olomouc, Olomouc Region, Česko, 779 00
- MUDr. Gregar, s.r.o.
-
-
Plzeň-město
-
Pilsen, Plzeň-město, Česko, 301 00
- A-Shine
-
-
Praha 8
-
Prague, Praha 8, Česko, 186 00
- MEDIENDO
-
-
-
-
-
Wuhan, Čína, 430030
- Tongji Hospital of Tongji University
-
-
Anhui
-
Hefei, Anhui, Čína, 230022
- The First Affiliated Hospital of Anhui Medical University
-
Hefei, Anhui, Čína, 230000
- Anhui Provincial Hospital
-
-
Changsha City
-
Kaifu District, Changsha City, Čína, 410008
- Xiangya Hospital Central South University
-
-
Chongqing Municipality
-
Chongqing, Chongqing Municipality, Čína, 400037
- The Affiliated 2nd Hosp. of Third Military Med. Univ. of PLA
-
Chongqing, Chongqing Municipality, Čína, 400038
- The First Hospital Affiliated to AMU (Southwest Hospital)
-
-
Guangdong
-
Guangzhou, Guangdong, Čína, 510655
- The Sixth Affiliated Hospital, Sun Yat-sen University
-
-
Hubei
-
Wuhan, Hubei, Čína, 430022
- Union Hospital Tongji Medical College Huazhong University of Science and Technology
-
Wuhan, Hubei, Čína, 430060
- Renmin Hospital of Wuhan University
-
-
Jiangsu
-
Nanjing, Jiangsu, Čína, 210008
- The Affiliated Drum Tower Hospital of Nanjing University
-
Nanjing, Jiangsu, Čína, 210029
- Zhongda Hospital Southeast University
-
Nanjing, Jiangsu, Čína, 211106
- Nanjing Medical University - Nanjing Jiangning Hospital
-
-
Jiangxi
-
Pingxiang, Jiangxi, Čína, 337055
- Jiangxi Pingxiang People's Hospital
-
-
Jilin
-
Jilin, Jilin, Čína, 132011
- Jilin Central General Hospital
-
-
Shandong
-
Jinan, Shandong, Čína, 250021
- Shandong Provincial Hospital
-
Jinan, Shandong, Čína, 250014
- Qilu Hospital of Shandong University
-
Liaocheng, Shandong, Čína, 252000
- Liaocheng People's Hospital
-
Qingdao, Shandong, Čína, 266000
- The Affiliated Hospital Of Qingdao University
-
Taian, Shandong, Čína, 271000
- Taian City Central Hospital
-
-
Shanghai Municipality
-
Shanghai, Shanghai Municipality, Čína, 200025
- Shanghai Jiaotong University School of Medicine Ruijin Hospital
-
Shanghai, Shanghai Municipality, Čína, 200127
- Renji Hospital Affliated to Shanghai Jiaotong University
-
-
Sichuan
-
Chengdu, Sichuan, Čína, 610041
- West China Hospital, Sichuan University
-
-
Yunnan
-
Kunming, Yunnan, Čína, 650034
- The First People's Hospital of Yunnan Province
-
Kunming, Yunnan, Čína, 650032
- Kunming Medical College Affiliated First Hospital
-
-
Zhejiang
-
Hangzhou, Zhejiang, Čína, 310016
- Sir Run Run Shaw Hospital
-
Hangzhou, Zhejiang, Čína, 310003
- First Affiliated Hosp of College of Med, Zhejiang University
-
Hangzhou, Zhejiang, Čína, 310000
- The Second Affiliated Hospital of Zhejiang University School of Med
-
Wenzhou, Zhejiang, Čína, 325027
- The Second Affiliated Hospital YuYing Childens Hospital of Wenzhou Medical university
-
-
-
-
-
A Coruña, Španělsko, 15006
- Complexo Hospitalario Universitario A Coruña, CHUAC
-
Alicante, Španělsko, 3004
- Instituto de Ciencias Médicas
-
Girona, Španělsko, 17007
- Hospital Universitari de Girona
-
Huelva, Španělsko, 21005
- Hospital Universitario Juan Ramon Jimenez
-
Las Palmas de Gran Canaria, Španělsko, 35010
- Hospital de Gran Canaria Dr. Negrín
-
Madrid, Španělsko, 28046
- Hospital Universitario La Paz
-
Oviedo, Španělsko, 3306
- Hospital Universitario Central de Asturias
-
-
Andalusia
-
Seville, Andalusia, Španělsko, 41013
- Hospital Universitario Virgen del Rocío
-
-
Baleares Islands
-
Palma de Mallorca, Baleares Islands, Španělsko, 07120
- Hospital Universitari Son Espases
-
-
Cantabria
-
Santander, Cantabria, Španělsko, 39008
- Hospital Universitario Marqués de Valdecilla
-
-
Madrid
-
Fuenlabrada, Madrid, Španělsko, 28942
- Hospital De Fuenlabrada
-
-
Valencia
-
Sagunto, Valencia, Španělsko, 46520
- Hospital Gen. Juan Ramon Jimenez - Depto de Digestivo
-
-
-
-
-
Bern, Švýcarsko, 3010
- Inselspital Bern
-
Sankt Gallen, Švýcarsko, 9007
- Kantonsspital St.Gallen
-
Zurich, Švýcarsko, 8091
- Universitatsspital Zurich
-
-
Canton of Bern
-
Bern, Canton of Bern, Švýcarsko, 3012
- Gastroenterologische Praxis Balsiger, Seibold & Partner
-
-
Kritéria účasti
Kritéria způsobilosti
Věk způsobilý ke studiu
Přijímá zdravé dobrovolníky
Popis
Kritéria pro zařazení:
- Dokončete studii AMAN (NCT03518086) s podáním alespoň 1 studovaného léčiva a bez předčasného ukončení studovaného léčiva.
- Jsou ochotni a schopni dokončit plánovaná hodnocení studie, včetně endoskopie a denního zápisu do deníku.
- Pokud je žena, musí splňovat požadavky na antikoncepci.
Kritéria vyloučení:
- U účastníků byla během indukční studie AMAN (NCT03518086) diagnostikována Crohnova choroba nebo neklasifikované zánětlivé onemocnění střev (indeterminovaná kolitida).
- Účastníci s resekcí střeva nebo jiným chirurgickým zákrokem pro léčbu UC během předchozí indukční studie AMAN (NCT03518086), nebo pravděpodobně budou vyžadovat chirurgický zákrok pro léčbu UC během studie AMBG.
- Účastníci s prokázanou dysplazií tlustého střeva nebo jim byla diagnostikována rakovina gastrointestinálního traktu během studie AMAN (NCT03518086).
- U účastníků byla během indukční studie AMAN (NCT03518086) diagnostikována klinicky závažná infekce, včetně, ale bez omezení na ně, hepatitidy B, hepatitidy C, HIV/AIDS a aktivní tuberkulózy (TB).
- Účastníci, kteří zahájí novou zakázanou medikaci během indukční studie AMAN (NCT03518086).
- Účastníci s určitými laboratorními abnormalitami před zahájením AMBG, které by vyžadovaly trvalé ukončení léčby studovaným lékem.
Studijní plán
Jak je studie koncipována?
Detaily designu
- Primární účel: Léčba
- Přidělení: Nerandomizované
- Intervenční model: Paralelní přiřazení
- Maskování: Dvojnásobek
Zbraně a zásahy
Skupina účastníků / Arm |
Intervence / Léčba |
|---|---|
|
Komparátor placeba: Období údržby: Miri Induction Responder (IR) - Placebo (PBO) Subkutánní (SC)
Účastníci, kteří reagovali na zaslepený mirikizumab (miri) v týdnu 12 v indukční studii (LUCENT-1), byli randomizováni tak, že vysadili mirikizumab a začali dostávat PBO SC každé 4 týdny (Q4W) od týdne 0 udržovací studie (LUCENT-2) do týdne 40 nebo dokud nebyla potvrzena ztráta odpovědi.
|
Spravováno SC
|
|
Experimentální: Období údržby: Miri IR - 200 miligramů (mg) Miri SC
Účastníci, kteří reagovali na zaslepený mirikizumab v týdnu 12 v indukční studii (LUCENT-1), byli randomizováni k pokračování v podávání 200 mg mirikizumabu SC Q4W od týdne 0 LUCENT-2 do týdne 40 nebo dokud nebyla potvrzena ztráta odpovědi.
|
Spravováno SC
Ostatní jména:
|
|
Experimentální: Maintenance Period: PBO IR - PBO SC
Participants who were responders to blinded placebo at Week 12 in induction study (LUCENT-1) continue to receive blinded placebo SC Q4W from Week 0 of LUCENT-2 until Week 40 or until loss of response was confirmed.
|
Spravováno SC
|
|
Experimentální: Maintenance Period: Miri IR - PBO SC - ME2 Cohort
Participants in the ME2 Cohort who were responders to blinded mirikizumab (miri) at Week 12 in induction study (LUCENT-1) randomized to withdraw from mirikizumab and start receiving PBO SC every 4 weeks (Q4W) from Week 0 of maintenance study (LUCENT-2) until Week 40 or until loss of response was confirmed.
|
Spravováno SC
|
|
Experimentální: Maintenance Period: Miri IR - 200 mg Miri SC - ME2 Cohort
Participants in the ME2 Cohort who were responders to blinded mirikizumab at Week 12 in induction study (LUCENT-1) randomized to continue to receive 200 mg mirikizumab SC Q4W from Week 0 of LUCENT-2 until Week 40 or until loss of response was confirmed.
|
Spravováno SC
Ostatní jména:
|
|
Experimentální: Maintenance Period: PBO IR - PBO SC - ME2 Cohort
Participants in the ME2 Cohort who were responders to blinded placebo at Week 12 in induction study (LUCENT-1) continue to receive blinded placebo SC Q4W from Week 0 of LUCENT-2 until Week 40 or until loss of response was confirmed.
|
Podáno IV
Ostatní jména:
Spravováno SC
|
|
Experimentální: Loss of Response (LOR) Rescue Period: LOR Cohort-300 mg Miri IV
Participants who received blinded PBO SC or blinded 200 mg mirikizumab SC Q4W during maintenance period and experienced a loss of response at or after Week 12, received rescue therapy with open label 300 mg mirikizumab intravenous (IV) Q4W for 3 doses.
|
Podáno IV
Ostatní jména:
|
|
Experimentální: LOR Rescue Period: LOR Cohort-300 mg Miri IV - ME2 Cohort
Participants in the ME2 Cohort who received blinded PBO SC or blinded 200 mg mirikizumab SC Q4W during maintenance period and experienced a loss of response at or after Week 12, received rescue therapy with open label 300 mg mirikizumab intravenous (IV) Q4W for 3 doses.
|
Podáno IV
Ostatní jména:
|
|
Experimentální: Extended Induction: Induction Nonresponders - 300mg Miri IV
Participants who were nonresponders to blinded mirikizumab or placebo in induction study (LUCENT-1), received additional 3 doses of open label 300 mg mirikizumab IV Q4W during extended induction period from Week 0 of LUCENT-2 until Week 12.
|
Podáno IV
Ostatní jména:
|
|
Experimentální: Extended Induction: Induction Nonresponders - 300mg Miri IV - ME2 Cohort
Participants in the ME2 Cohort who were nonresponders to blinded mirikizumab or placebo in induction study (LUCENT-1), received additional 3 doses of open label 300 mg mirikizumab IV Q4W during extended induction period from Week 0 of LUCENT-2 until Week 12.
|
Podáno IV
Ostatní jména:
|
|
Experimentální: Open Label Maintenance: Delayed Responders - 200 mg Miri SC
Participants who initially did not respond to induction study (LUCENT-1), but responded to extended induction therapy at Week 12 of LUCENT-2 (delayed responders), received 200 mg mirikizumab SC Q4W during open label maintenance period from Week 12 until Week 40 or until early termination (rescue was not available for these participants).
|
Spravováno SC
Ostatní jména:
|
|
Experimentální: Open Label Maintenance: Delayed Responders - 200 mg Miri SC - ME2 Cohort
Participants in the ME2 Cohort who initially did not respond to induction study (LUCENT-1), but responded to extended induction therapy at Week 12 of LUCENT-2 (delayed responders), received 200 mg mirikizumab SC Q4W during open label maintenance period from Week 12 until Week 40 or until early termination (rescue was not available for these participants).
|
Spravováno SC
Ostatní jména:
|
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Percentage of Participants in Clinical Remission at Week 40 (Mirikizumab Induction Responders)
Časové okno: Week 40
|
Clinical remission at week 40 is defined as achieving a 9-point modified Mayo score for rectal bleeding=0, stool frequency=0 or 1 with ≥ 1 point decrease from baseline, and endoscopy=0 or 1 (excluding friability). Stool Frequency Subscore, based on the participant's diary and scored from 0 (normal number of stools) to 3 (5 or more stools than normal); Rectal Bleeding Subscore, based on the participant's diary and scored from 0 (no blood) to 3 (blood only passed); Endoscopy Subscore, based on central reading of colonoscopy or sigmoidoscopy and scored from 0 (normal or inactive disease) to 3 (severe disease, spontaneous bleeding, ulceration). Modified Intention-to-treat population (mITT): All randomized participants who received at least one dose of mirikizumab and who had a correctly measured Modified Mayo Score at baseline. Participants were analyzed according to the treatment arm to which they were randomized, regardless of the treatment actually received. |
Week 40
|
Sekundární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Farmakokinetika (PK): Clearance Mirikizumabu
Časové okno: Před podáním: Týdny 0, 4, 12, 24 a 40
|
Byla hodnocena clearance mirikizumabu.
|
Před podáním: Týdny 0, 4, 12, 24 a 40
|
|
Percentage of Participants in Endoscopic Remission at Week 40 (Mirikizumab Induction Responders)
Časové okno: Week 40
|
Endoscopic remission at week 40 is defined as achieving a Mayo endoscopic subscore of 0 or 1 (excluding friability) at Week 40.
Endoscopy subscore is based on colonoscopy or sigmoidoscopy and scored from 0 (normal or inactive disease) to 3 (severe disease, spontaneous bleeding, ulceration).
|
Week 40
|
|
Percentage of Participants With Histologic Remission at Week 40 (Mirikizumab Induction Responders)
Časové okno: Week 40
|
Histologic remission was assessed using the Geboes histologic scoring system developed for assessment of histologic disease activity in ulcerative colitis.
Remission was defined as Geboes histological subscore of 0 for grades: 2b (lamina propria neutrophils), and 3 (neutrophils in epithelium), and 4 (crypt destruction), and 5 (erosion or ulceration).
|
Week 40
|
|
Percentage of Participants in Symptomatic Remission at Week 40 (Mirikizumab Induction Responders)
Časové okno: Week 40
|
Symptomatic remission at week 40 is defined as a Mayo score for rectal bleeding=0, stool frequency=0 or 1 with ≥ 1 point decrease from baseline. Stool frequency subscore, based on the participant's diary and scored from 0 (normal number of stools) to 3 (5 or more stools than normal). Rectal bleeding subscore, based on the participant's diary and scored from 0 (no blood seen) to 3 (blood alone passed). |
Week 40
|
|
Percentage of Participants in Endoscopic Response at Week 40 (Mirikizumab Induction Responders)
Časové okno: Week 40
|
Endoscopic response at week 40 is defined as achieving at least a 1 point decrease from baseline in the Mayo endoscopic subscore.
|
Week 40
|
|
Percentage of Participants in Clinical Response at Week 40 (Mirikizumab Induction Responders)
Časové okno: Week 40
|
Clinical response at week 40 is defined as a decrease in the 9-point modified Mayo score (MMS) [rectal bleeding, stool frequency and the endoscopic findings] inclusive of >= 2 points and >=30% from baseline with either a decrease of rectal bleeding subscore of >=1 or rectal bleeding subscore of 0 or 1.The MMS is a composite score of ulcerative colitis disease activity calculated as the sum of three subscores: Stool frequency subscore, based on the participant's diary and scored from 0 (normal number of stools) to 3 (5 or more stools than normal); Rectal bleeding subscore, based on the participant's diary and scored from 0 (no blood seen) to 3 (blood alone passed); Endoscopy subscore, based on colonoscopy or sigmoidoscopy and scored from 0 (normal or inactive disease) to 3 (severe disease, spontaneous bleeding,ulceration).
|
Week 40
|
|
Change From Baseline to Week 40 in Health Related Quality of Life: Inflammatory Bowel Disease Questionnaire (IBDQ) Total Score (Mirikizumab Induction Responders)
Časové okno: Induction Baseline, Week 40
|
The IBDQ is a 32-item participant-completed questionnaire that measures 4 aspects of subjects' lives: symptoms directly related to the primary bowel disturbance, systemic symptoms, emotional function, and social function.
Responses are graded on a 7-point.
Likert scale in which 7 denotes "not a problem at all" and 1 denotes "a very severe problem."
Scores range from 32 to 224; a higher score indicates a better quality of life.
Least square (LS) Mean was calculated using analysis of covariance (ANCOVA) model for post-baseline measures: The ANCOVA model includes: treatment, baseline value, prior biologic or tofacitinib failure (yes/no), clinical remission status (yes/no) at AMAN Week 12, and region (North America/Europe/Other).
|
Induction Baseline, Week 40
|
|
Change From Baseline to Week 40 in Fecal Calprotectin (Mirikizumab Induction Responders)
Časové okno: Induction Baseline, Week 40
|
Fecal calprotectin is an indicator of inflammation in the colon with higher levels indicative of higher levels of inflammation.
Least square (LS) Mean was calculated using ANCOVA model for post-baseline measures: The ANCOVA model includes treatment, baseline value, prior biologic or tofacitinib failure (yes/no), corticosteroid use (yes/no) at AMAN baseline, region (North America/Europe/Other), Clinical Remission status (yes/no) at AMAN Week 12.
|
Induction Baseline, Week 40
|
|
Change From Baseline to Week 40 in Bowel Urgency Based on the Urgency Numeric Rating Scale (NRS) (Mirikizumab Induction Responders)
Časové okno: Induction Baseline, Week 40
|
The Urgency NRS is a single participant reported item that measures the severity for the urgency (sudden or immediate need) to have a bowel movement in the past 24 hours using an 11-point NRS ranging from 0 (no urgency) to 10 (worst possible urgency).
Higher scores indicate more severe urgency.
Least square (LS) Mean was calculated using mixed model repeated measures (MMRM) model for post-baseline measures: The MMRM model includes treatment, baseline value, visit, interaction of baseline value-by-visit, interaction of treatment-by-visit, prior biologic or tofacitinib failure (yes/no), baseline corticosteroid use (yes/no), clinical remission status (yes/no) at AMAN Week 12, and region (North America/Europe/Other).
|
Induction Baseline, Week 40
|
|
Percentage of Participants Hospitalized for Ulcerative Colitis (UC) (Mirikizumab Induction Responders)
Časové okno: Week 40
|
Percentage of participants hospitalized for UC.
Only hospitalizations associated with an adverse event with >=24 hours stay were recorded.
|
Week 40
|
Spolupracovníci a vyšetřovatelé
Sponzor
Vyšetřovatelé
- Ředitel studie: Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), Eli Lilly and Company
Publikace a užitečné odkazy
Obecné publikace
- Sands BE, D'Haens G, Clemow DB, Irving PM, Johns JT, Gibble TH, Abreu MT, Lee SD, Hisamatsu T, Kobayashi T, Dubinsky MC, Vermeire S, Siegel CA, Peyrin-Biroulet L, Moses RE, Milata J, Panaccione R, Dignass A. Three-Year Efficacy and Safety of Mirikizumab Following 152 Weeks of Continuous Treatment for Ulcerative Colitis: Results From the LUCENT-3 Open-Label Extension Study. Inflamm Bowel Dis. 2025 Jul 7;31(7):1876-1890. doi: 10.1093/ibd/izae253.
- Clemow DB, Dubinsky MC, Baygani SK, Sands BE, Keohane A, Danese S, Schreiber S, Walsh AJ, Hibi T, Gibble TH, Moses RE, Travis SPL. Bowel urgency in ulcerative colitis: effect of baseline urgency and change in urgency in response to mirikizumab. J Patient Rep Outcomes. 2025 Jul 1;9(1):75. doi: 10.1186/s41687-025-00906-0.
- Panaccione R, Chan-Diehl F, Baygani S, Fisher DA, Moses RE, Siegmund B, Walsh A, Kobayashi T, Dulai PS, Travis S. Fecal Calprotectin and C-Reactive Protein Association With Histologic and Endoscopic Endpoints in Mirikizumab-Treated Patients With Ulcerative Colitis. Crohns Colitis 360. 2025 Jun 14;7(2):otaf043. doi: 10.1093/crocol/otaf043. eCollection 2025 Apr.
- Danese S, Dignass A, Matsuoka K, Ferrante M, Long M, Redondo I, Moses R, Maier S, Hunter Gibble T, Morris N, Milch C, Abreu MT. Early and Sustained Symptom Control with Mirikizumab in Patients with Ulcerative Colitis in the Phase 3 LUCENT Programme. J Crohns Colitis. 2024 Nov 4;18(11):1845-1856. doi: 10.1093/ecco-jcc/jjae088.
- Long MD, Schreiber S, Hibi T, Gibble TH, Fisher DA, Park G, Moses RE, Higgins PDR, Lindsay JO, Lee SD, Escobar R, Jairath V. Association of Bowel Urgency With Quality-of-Life Measures in Patients With Moderately-to-Severely Active Ulcerative Colitis: Results From Phase 3 LUCENT-1 (Induction) and LUCENT-2 (Maintenance) Studies. Crohns Colitis 360. 2024 Jan 6;6(1):otae001. doi: 10.1093/crocol/otae001. eCollection 2024 Jan.
- Sands BE, Feagan BG, Hunter Gibble T, Traxler KA, Morris N, Eastman WJ, Schreiber S, Jairath V, Long MD, Armuzzi A. Mirikizumab Improves Quality of Life in Patients With Moderately-to-Severely Active Ulcerative Colitis: Results From the Phase 3 LUCENT-1 Induction and LUCENT-2 Maintenance Studies. Crohns Colitis 360. 2023 Nov 7;5(4):otad070. doi: 10.1093/crocol/otad070. eCollection 2023 Oct.
- Chua L, Friedrich S, Zhang XC. Mirikizumab Pharmacokinetics in Patients with Moderately to Severely Active Ulcerative Colitis: Results from Phase III LUCENT Studies. Clin Pharmacokinet. 2023 Oct;62(10):1479-1491. doi: 10.1007/s40262-023-01281-z. Epub 2023 Aug 23.
- D'Haens G, Dubinsky M, Kobayashi T, Irving PM, Howaldt S, Pokrotnieks J, Krueger K, Laskowski J, Li X, Lissoos T, Milata J, Morris N, Arora V, Milch C, Sandborn W, Sands BE; LUCENT Study Group. Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis. N Engl J Med. 2023 Jun 29;388(26):2444-2455. doi: 10.1056/NEJMoa2207940.
- Magro F, Pai RK, Kobayashi T, Jairath V, Rieder F, Redondo I, Lissoos T, Morris N, Shan M, Park M, Peyrin-Biroulet L. Resolving Histological Inflammation in Ulcerative Colitis With Mirikizumab in the LUCENT Induction and Maintenance Trial Programmes. J Crohns Colitis. 2023 Oct 20;17(9):1457-1470. doi: 10.1093/ecco-jcc/jjad050.
- Lee SD, Ehrlich AC, Pellanda P, Kaiser C, Todd K, Moses R, Walsh A. Long-Term Safety of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis: An Integrated 2-Year Safety Analysis. Am J Gastroenterol. 2025 Dec 1;120(12):2857-2866. doi: 10.14309/ajg.0000000000003407. Epub 2025 Mar 12.
- Hart A, Navabi S, D'Haens G, Matsuoka K, Martin-Arranz MD, Atreya R, Samaan KH, Dhesi E, Redondo I, Zhu B, Paulissen J, Zaremba-Pechmann L, Baygani S, Limdi J, Laharie D, Danese S. Effect of Mirikizumab on Clinical and Endoscopic Outcomes Based on Prior Advanced Therapy Failure in Patients With Moderately to Severely Active Ulcerative Colitis. United European Gastroenterol J. 2026 May;14(4):e70214. doi: 10.1002/ueg2.70214.
- Ran Z, Chen Y, Miao Y, Wang Y, Gao X, Zhong J, Ding X, Wang C, Zhang X, Ding Y, Hu N, Tang D, Yu J, Qian C, Shen J. Mirikizumab as Induction and Maintenance Therapy in Chinese Patients with Ulcerative Colitis: A Subpopulation Analysis of the Randomized, Global Phase 3 LUCENT-1 and LUCENT-2 Trials. BioDrugs. 2026 May 12. doi: 10.1007/s40259-026-00776-y. Online ahead of print.
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia (Aktuální)
Primární dokončení (Aktuální)
Dokončení studie (Aktuální)
Termíny zápisu do studia
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Aktuální)
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Aktuální)
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Více informací
Termíny související s touto studií
Klíčová slova
Další relevantní podmínky MeSH
- Střevní nemoci
- Nemoci trávicího systému
- Gastrointestinální onemocnění
- Onemocnění tlustého střeva
- Gastroenteritida
- Kolitida
- Kolitida, ulcerózní
- Zánětlivá onemocnění střev
- Fyziologické účinky léků
- Protizánětlivé látky
- Agenti periferního nervového systému
- Gastrointestinální látky
- Antirevmatická činidla
- Agenti smyslového systému
- Analgetika, nenarkotika
- Analgetika
- Protizánětlivé látky, nesteroidní
- Prostředky proti vředům
- Mirikizumab
Další identifikační čísla studie
- 16823
- I6T-MC-AMBG (Jiný identifikátor: Eli Lilly and Company)
- 2017-003238-96 (Číslo EudraCT)
Plán pro data jednotlivých účastníků (IPD)
Plánujete sdílet data jednotlivých účastníků (IPD)?
Popis plánu IPD
Časový rámec sdílení IPD
Kritéria přístupu pro sdílení IPD
Typ podpůrných informací pro sdílení IPD
- PROTOKOL STUDY
- MÍZA
- CSR
Informace o lécích a zařízeních, studijní dokumenty
Studuje lékový produkt regulovaný americkým FDA
Studuje produkt zařízení regulovaný americkým úřadem FDA
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .
Klinické studie na Ulcerózní kolitida
-
Baylor College of MedicineMichael E. DeBakey VA Medical CenterZápis na pozvánkuAktivní C. Difficile ColitisSpojené státy
-
Fondazione IRCCS Policlinico San Matteo di PaviaNáborImunitní kontrolní inhibitory indukovaná kolitida vyvolaná | Pokročilý rakovina kůže melanomu, nemasokrým karcinomem plic, adenokarcinom ledvin | Ileo-colitis | Imunitní zprostředkovaná kolitidaItálie
Klinické studie na Mirikizumab IV
-
Groupe d'Etude Therapeutique des Affections Inflammatoires...NáborCrohnova nemoc (CD)Francie
-
Eli Lilly and CompanyNáborCrohnova nemocBelgie, Maďarsko, Izrael, Spojené státy, Itálie, Čína, Německo, Polsko, Brazílie, Kanada
-
Eli Lilly and CompanyNáborCrohnova nemoc | Kolitida, ulcerózníBelgie, Maďarsko, Izrael, Spojené státy, Itálie, Čína, Německo, Polsko, Brazílie, Kanada
-
Eli Lilly and CompanyStaženo
-
Eli Lilly and CompanyDokončeno
-
Eli Lilly and CompanyDokončenoUlcerózní kolitidaSpojené státy, Belgie, Francie, Německo, Polsko, Japonsko, Izrael, Itálie, Spojené království, Kanada, Jižní Korea
-
University of North Carolina, Chapel HillEli Lilly and CompanyNáborPouchitida | Sáček, Ileale | Sáčky, IleoanalSpojené státy
-
Eli Lilly and CompanyZatím nenabírámeZánětlivé onemocnění střev | LaktaceSpojené státy, Španělsko, Dánsko, Izrael, Itálie, Německo, Polsko, Kanada